2seventy Bio Stock Probability of Future Stock Price Finishing Over 8.16
| TSVT Stock | USD 3.99 0.03 0.76% |
2Seventy |
2Seventy Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of 2Seventy Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for 2Seventy Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| 2Seventy Bio generated a negative expected return over the last 90 days | |
| 2Seventy Bio has high historical volatility and very poor performance | |
| 2Seventy Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 100.39 M. Net Loss for the year was (217.57 M) with loss before overhead, payroll, taxes, and interest of (183.46 M). | |
| 2Seventy Bio currently holds about 357.93 M in cash with (166.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 91.0% of the company shares are owned by institutional investors |
2Seventy Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of 2Seventy Stock often depends not only on the future outlook of the current and potential 2Seventy Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. 2Seventy Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 49.3 M | |
| Cash And Short Term Investments | 217 M |
2Seventy Bio Technical Analysis
2Seventy Bio's future price can be derived by breaking down and analyzing its technical indicators over time. 2Seventy Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of 2Seventy Bio. In general, you should focus on analyzing 2Seventy Stock price patterns and their correlations with different microeconomic environments and drivers.
2Seventy Bio Predictive Forecast Models
2Seventy Bio's time-series forecasting models is one of many 2Seventy Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary 2Seventy Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about 2Seventy Bio
Checking the ongoing alerts about 2Seventy Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for 2Seventy Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| 2Seventy Bio generated a negative expected return over the last 90 days | |
| 2Seventy Bio has high historical volatility and very poor performance | |
| 2Seventy Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 100.39 M. Net Loss for the year was (217.57 M) with loss before overhead, payroll, taxes, and interest of (183.46 M). | |
| 2Seventy Bio currently holds about 357.93 M in cash with (166.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 91.0% of the company shares are owned by institutional investors |
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.